Rochester General Health System is, effective immediately and until further notice, suspending the use of power morcellation in gynecologic surgeries, including hysterectomies.
The Food and Drug Administration (FDA) has issued an advisory stating that the use of power morcellation in some surgeries may spread cancer.
Morcellation is a technique used in minimally invasive/robotic uterine surgery that uses a power tool to cut tissue while still in the body so it can be removed through the smaller incisions.
“Upon review of the FDA communication, RGHS is suspending use of the power morcellator until further notice,” said Eugene Toy MD, Chief, OB-GYN/RGHS. “A formal policy regarding the use of morcellation in gynecologic surgery will be established next month during a special meeting of the GYN OR committee.”
Dr. Toy says that patients scheduled to have surgery with the use of power morcellation will be counseled on this policy change and offered alternative surgical options in the meantime.
Monday, July 15, 2019
The expansion is the first phase of a $4.5 million project to expand cancer services at Linden Oaks and it will greatly improve access to care for patients with breast cancer and other breast conditions.Read News Article
Wednesday, June 26, 2019
The new Medical Village features a new OB/GYN, cardiac and pulmonary rehab as well as physical, occupational and speech therapy.Read News Article